Elekta aims to provide the highest level of cancer treatment possible, which means combining the most advanced technology with the most effective treatment techniques. In addition to working with industry and academic leaders through collaborative sponsored research programs, Elekta has its own extensive research and development program, which has resulted in a patent portfolio covering many important innovations in cancer care.

In accordance with Section 287(a) of Title 35 of the United States Code, and Section 15 of the UK’s Intellectual Property Act 2014, the reader is hereby placed on notice of Elekta's intellectual property rights for the following products protected by granted patents in the United States and the United Kingdom.

Agility™

Beam Modulator™

Connexion™

Elekta Axesse™

Elekta Infinity™

Elekta Synergy®

Extend™

  • EP 2,186,489 B1
  • EP 2,112,457 B1
  • US 8,393,821 B2
  • US 8,100,132 B2
  • US 8,088,083 B2

iViewGT™

Leksell Coordinate Frame G

  • US 8,221,435 B2,
  • EP 1,503,689 B1


 

Leksell Gamma Knife® Icon™

  • US 6,931,096 B2
  • US 7,313,222 B2
  • US 6,968,036 B2
  • US 7,492,866 B2
  • US 7,729,473 B2
  • EP 1,540,668 B1
  • EP 1,540,667 B1
  • EP 1,761,307 B1
  • EP 1,868,684 B1
  • EP 2,326,390 B1

Leksell Gamma Knife® Perfexion™

  • US 6,931,096 B2,
  • US 7,313,222 B2,
  • US 6,968,036 B2,
  • US 7,492,866 B2,
  • EP 1,540,668 B1,
  • EP 1,540,667 B1,
  • EP 1,761,307 B1,
  • EP 1,868,684 B1,

Leksell GammaPlan®

  • EP 2,069,016 B1

Precise Treatment Table

Symmetry™

Versa HD™

XVI

XVI 5.0.1

Patent licensing

Elekta aims to provide the highest level of cancer treatment possible, which means combining the most advanced technology with the most effective treatment techniques. In addition to working with industry and academic leaders through research programmes, Elekta also acquires mature technology which has been proven to increase treatment accuracy, enhance the patient experience or improve treatment outcomes.

Elekta understands the importance of intellectual property and the role it plays in encouraging innovation and entrepreneurialism, having an extensive patent portfolio which covers many of the most important innovations in cancer care of the last four decades. However, we are always seeking new opportunities to augment our product range and intellectual property portfolio.

If you have a patented or patent pending cancer treatment technology or system that you think Elekta might be interested in, we want to hear from you. Please send your inquiry along with any additional information and contact details by completing the form below:

 
Name: *
 
Company/institution:  
 
Email:*
 
Further details:
 
Upload a file: